Craig Johnson

Craig Johnson

Directeur/Membre du Conseil chez HERON THERAPEUTICS, INC.

Fortune : 296 575 $ au 31/05/2026

64 ans
Health Technology
Commercial Services
Process Industries

Profil

Craig A. Johnson is currently Lead Independent Director at Heron Therapeutics, Inc. since 2020 and Lead Independent Director at Aurinia Pharmaceuticals, Inc. starting in 2026.
Former roles include Independent Director at La Jolla Pharmaceutical Co. from 2013 to 2022, Independent Director at Mirati Therapeutics, Inc. from 2013 to 2024, Independent Director at Ardea Biosciences, Inc. from 2008 to 2012, Independent Director at DMK Pharmaceuticals Corp.
from 2011 to 2014, Director at Veracyte SD, Inc. from 2015 to 2018, Director at Tetraphase Pharmaceuticals, Inc., Independent Director at Odonate, Inc. from 2017 to 2022, Chief Financial Officer at PURE Bioscience, Inc. in 2012, Chief Financial Officer, Secretary & Senior VP at NovaDel Pharma, Inc. from 2010 to 2011, Chief Financial Officer & Senior VP-Operations at MitoKor, Inc. from 1994 to 2004, Vice President-Sales at Philip Morris USA, Inc. from 1991 to 2009, Vice President at Raptor Pharmaceuticals Corp.
from 2009 to 2010, Chief Financial Officer & Vice President at TorreyPines Therapeutics, Inc. from 2004 to 2009, Chief Financial Officer & Vice President at TPTX, Inc. from 2004 to 2010, and Vice President at Horizon Pharmaceutical LLC from 2009 to 2010.
Education includes an undergraduate degree from The University of Michigan-Dearborn conferred in 1984.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
04/06/2026 14 592 ( 0,01% ) 223 695 $ 31/05/2026
14/04/2026 83 770 ( 0,04% ) 72 880 $ 31/05/2026

Postes actifs de Craig Johnson

SociétésPosteDébut
HERON THERAPEUTICS, INC. Directeur/Membre du Conseil 13/01/2014
AURINIA PHARMACEUTICALS INC. Directeur/Membre du Conseil 07/11/2024

Anciens postes connus de Craig Johnson

SociétésPosteFin
MIRATI THERAPEUTICS Directeur/Membre du Conseil 23/01/2024
LA JOLLA PHARMACEUTICAL COMPANY Directeur/Membre du Conseil 22/08/2022
ODONATE, INC. Directeur/Membre du Conseil 01/01/2022
Directeur/Membre du Conseil 01/01/2018
DMK PHARMACEUTICALS CORPORATION Directeur/Membre du Conseil 25/08/2014
Voir l'expérience en détail de Craig Johnson

Formation de Craig Johnson

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

55

Relations au 1er degré

18

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées18

Health Technology

Health Technology

Process Industries

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Non-Durables

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Craig Johnson